Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Could a SARS-CoV-2 accessory protein be responsible for certain COVID-19 symptoms?

Researchers highlight the potential causes of some COVID-19 symptoms. Early in the pandemic, the hallmark symptoms of COVID-19 include cough, fever, and shortness of breath. As the pandemic has evolved, more symptoms have emerged, such as loss of smell and taste, headache, intestinal issues, and abdominal pains.

10 Feb 2021

Study investigates how people are receiving and interpreting information about coronavirus

Swedish Television (SVT) remains the most common and trustworthy news source about the coronavirus for Swedes. Healthcare professionals are the professional group that Swedes have the most confidence in.

10 Feb 2021

Reducing obesity may prevent up to half of new type 2 diabetes cases

Reducing the prevalence of obesity may prevent up to half of new Type 2 diabetes cases in the United States, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

10 Feb 2021

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Researchers shows a fully human immunoglobulin (IgG) that potently inhibits SARS-CoV-2 infection.

10 Feb 2021

Study finds low SARS-CoV-2 antibody responses in asymptomatic and mild COVID-19 cases

Researchers at Northwestern University have noted high rates of asymptomatic and mild infection in a large community-based cohort and low levels of anti-SARS-CoV-2 immunoglobulin G antibody (IgG) in the general population of previously exposed people.

10 Feb 2021

Nature Inspired Materials

An Interview with Dr. Lauren Zarzar, exploring how the natural world can serve as both inspiration and model for the invention of dynamic materials, to be presented at Pittcon 2021

From Pittcon 10 Feb 2021

BioRescue research project exemplifies challenges posed by global pandemic

The BioRescue research project, a program aiming at saving the northern white rhinoceros from extinction, exemplifies the challenges to overcome when conducting research and conservation in an international consortium in times of a global pandemic.

10 Feb 2021

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) who test positive for SARS-CoV-2 and who are at high risk for progressing to severe COVID-19.

10 Feb 2021

UCI Health creates new system to deliver monoclonal antibodies in COVID-19 patients

Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them can be a challenge.

10 Feb 2021

Smartphones could help manage chronic cardiopulmonary disease, predict next pandemic

Photoplethysmography (PPG) is a simple optical technique used to detect volumetric changes in peripheral blood circulation. It's used in smart watches, for example, to monitor pulse and heart rate, but PPG biosensors are also found in millions of smartphones, but without any current clinical applications.

10 Feb 2021

Scientists urge health agencies to invest in COVID-19 vaccine development to prevent next pandemic

As new COVID-19 variants begin to throw vaccine efficacy in question, two leading scientists are calling for health agencies to invest in the development of vaccines that would be broadly effective against many different variants and strains of potential pandemic viruses.

10 Feb 2021

Relaxed control measures are driving wintertime outbreaks of COVID-19

Wintertime outbreaks of COVID-19 have been largely driven by whether people adhere to control measures such as mask wearing and social distancing, according to a study published Feb. 8 in Nature Communications by Princeton University researchers.

10 Feb 2021

Acceptance of COVID-19 vaccine has increased significantly under Biden administration

Under the Biden Administration, New Yorkers' acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available and this January, 64% reported they would take it.

9 Feb 2021

Fred Hutch researchers predict a 4th wave of SARS-CoV-2

Recently, researchers from France and the USA analyzed the complexities of vaccine implementation during the 3rd wave of SARS-CoV-2 infections and potentially future waves, using a mathematical model calibrated to data from King County, Washington.

9 Feb 2021

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Researchers in the United States and Canada have conducted a study showing that just a single dose of either the Pfizer-BioNTech or Moderna vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is likely to protect against emerging variants.

9 Feb 2021

SARS-CoV-2 B.1.1.7 may soon become the dominant variant in US

A team of scientists from the United States has recently explored the prevalence and transmission dynamics of the B.1.1.7 variant (UK variant) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the United States. The study reveals that because of 35-45% increased transmissibility, B.1.1.7 may soon become the US's dominant variant. The study is currently available on the medRxiv* preprint server.

9 Feb 2021

Pandemic News and Research

Further Reading

Could a SARS-CoV-2 accessory protein be responsible for certain COVID-19 symptoms?

Study investigates how people are receiving and interpreting information about coronavirus

Reducing obesity may prevent up to half of new type 2 diabetes cases

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Study finds low SARS-CoV-2 antibody responses in asymptomatic and mild COVID-19 cases

Nature Inspired Materials

BioRescue research project exemplifies challenges posed by global pandemic

FDA issues EUA for bamlanivimab and etesevimab for COVID-19 treatment

UCI Health creates new system to deliver monoclonal antibodies in COVID-19 patients

Smartphones could help manage chronic cardiopulmonary disease, predict next pandemic

Scientists urge health agencies to invest in COVID-19 vaccine development to prevent next pandemic

Relaxed control measures are driving wintertime outbreaks of COVID-19

Acceptance of COVID-19 vaccine has increased significantly under Biden administration

Fred Hutch researchers predict a 4th wave of SARS-CoV-2

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

SARS-CoV-2 B.1.1.7 may soon become the dominant variant in US

New study to evaluate the effectiveness of drugs on preventing COVID-19 progression

Direct exposure to deadly fires increases the risk for mental health disorders

Model estimates COVID-19 cases in the U.S. to be three times greater than reported

People with dementia found to have significantly increased risk for COVID-19

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News